Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 415

    2.

    Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.

    Bluthenthal RN, Ridgeway G, Schell T, Anderson R, Flynn NM, Kral AH.

    Addiction. 2007 Apr;102(4):638-46. Epub 2007 Feb 6.

    PMID:
    17286637
    [PubMed - indexed for MEDLINE]
    4.

    Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States metropolitan areas.

    Gleghorn AA, Wright-De Agüero L, Flynn C.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S30-6.

    PMID:
    9663621
    [PubMed - indexed for MEDLINE]
    5.

    Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.

    Gleghorn AA, Gee G, Vlahov D.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S89-93.

    PMID:
    9663630
    [PubMed - indexed for MEDLINE]
    6.

    Access to syringes in three Russian cities: implications for syringe distribution and coverage.

    Sarang A, Rhodes T, Platt L.

    Int J Drug Policy. 2008 Apr;19 Suppl 1:S25-36. Epub 2008 Mar 3.

    PMID:
    18313910
    [PubMed - indexed for MEDLINE]
    7.

    A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.

    Finlinson HA, Oliver-Vélez D, Deren S, Cant JG, Colón HM, Robles RR, Kang SY, Andía JF.

    Subst Use Misuse. 2006;41(9):1313-36.

    PMID:
    16861181
    [PubMed - indexed for MEDLINE]
    8.

    Pharmacy access to sterile syringes for injection drug users: attitudes of participants in a syringe exchange program.

    Junge B, Vlahov D, Riley E, Huettner S, Brown M, Beilenson P.

    J Am Pharm Assoc (Wash). 1999 Jan-Feb;39(1):17-22.

    PMID:
    9990182
    [PubMed - indexed for MEDLINE]
    9.

    Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.

    Pouget ER, Deren S, Fuller CM, Blaney S, McMahon JM, Kang SY, Tortu S, Andia JF, Des Jarlais DC, Vlahov D.

    J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):471-7.

    PMID:
    16010172
    [PubMed - indexed for MEDLINE]
    10.

    Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users.

    Vickerman P, Hickman M, Rhodes T, Watts C.

    J Acquir Immune Defic Syndr. 2006 Jul;42(3):355-61.

    PMID:
    16645549
    [PubMed - indexed for MEDLINE]
    11.

    A syringe prescription program to prevent infectious disease and improve health of injection drug users.

    Rich JD, McKenzie M, Macalino GE, Taylor LE, Sanford-Colby S, Wolf F, McNamara S, Mehrotra M, Stein MD.

    J Urban Health. 2004 Mar;81(1):122-34.

    PMID:
    15047791
    [PubMed - indexed for MEDLINE]
    12.

    Correlates of unsafe syringe acquisition and disposal among injection drug users in Baltimore, Maryland.

    Golub ET, Bareta JC, Mehta SH, McCall LD, Vlahov D, Strathdee SA.

    Subst Use Misuse. 2005;40(12):1751-64.

    PMID:
    16419554
    [PubMed - indexed for MEDLINE]
    13.

    Expanding access to sterile syringes through pharmacies: assessment of New York's Expanded Syringe Access Program.

    Tesoriero JM, Battles HB, Klein SJ, Kaufman E, Birkhead GS.

    J Am Pharm Assoc (2003). 2009 May-Jun;49(3):407-16.

    PMID:
    19443321
    [PubMed - indexed for MEDLINE]
    14.

    Safe syringe disposal is related to safe syringe access among HIV-positive injection drug users.

    Coffin PO, Latka MH, Latkin C, Wu Y, Purcell DW, Metsch L, Gomez C, Gourevitch MN; INSPIRE Study Group.

    AIDS Behav. 2007 Sep;11(5):652-62. Epub 2006 Oct 12.

    PMID:
    17053854
    [PubMed - indexed for MEDLINE]
    15.

    Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.

    Cleland CM, Deren S, Fuller CM, Blaney S, McMahon JM, Tortu S, Des Jarlais DC, Vlahov D.

    Health Educ Behav. 2007 Apr;34(2):390-403. Epub 2006 Jun 30. Erratum in: Health Educ Behav. 2007 Jun;34(3):551.

    PMID:
    16816027
    [PubMed - indexed for MEDLINE]
    16.

    Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001.

    Des Jarlais DC, McKnight C, Friedmann P.

    J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S73-6.

    PMID:
    12489620
    [PubMed - indexed for MEDLINE]
    17.

    New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.

    Coffin PO, Linas BP, Factor SH, Vlahov D.

    J Urban Health. 2000 Dec;77(4):781-93.

    PMID:
    11194317
    [PubMed - indexed for MEDLINE]
    18.

    Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors' use of sterile syringes.

    Cooper HL, Des Jarlais DC, Ross Z, Tempalski B, Bossak B, Friedman SR.

    Am J Public Health. 2011 Jun;101(6):1118-25. Epub 2010 Nov 18.

    PMID:
    21088267
    [PubMed - indexed for MEDLINE]
    19.

    Access to sterile syringes for injecting drug users in New York City: politics and perception (1984-2010).

    Heller D, Paone D.

    Subst Use Misuse. 2011;46(2-3):140-9.

    PMID:
    21303234
    [PubMed - indexed for MEDLINE]
    20.

    Organizational issues in conducting tuberculosis screening at a syringe exchange program.

    Paone D, Perlman DC, Perkins MP, Kochems LM, Salomon N, Des Jarlais DC.

    J Subst Abuse Treat. 1998 May-Jun;15(3):229-34.

    PMID:
    9633035
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk